Cerebrospinal Fluid (CSF) Management Market driven by Hydrocephalus and Increase in Shunting Procedures

The global cerebrospinal fluid (CSF) management market is projected to reach USD 1.56 billion by 2022 from an estimated USD 1.26 billion in 2017 at a CAGR of 4.4%.

The cerebrospinal fluid (CSF) management market is well established owing to the dominance by prominent market players. In 2016, Medtronic (Ireland), DePuy Synthes (a Johnson & Johnson Company) (US), B. Braun (Germany), and Integra (US) held a majority share of the global cerebrospinal fluid (CSF) management market.

Medtronic (Ireland), dominated the cerebrospinal fluid (CSF) management market in 2016. In the field of CSF management, the company offers CSF shunts, external drainage systems, and accessories. The company focuses on enhancing its product offering by developing and acquiring new products, wraparound programs, and solutions to meet the needs of multiple customers. The company also focuses on developing innovative products and invests in R&D activities. Medtronic invested USD 2.2 billion, USD 1.6 billion, and USD 1.5 billion on R&D in 2016, 2015, and 2014, respectively. Medtronic conducts various training programs to support its end users that ensure effective product use and best possible healthcare results.

Download Free PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=160672575

Medtronic markets its products through direct sales representatives in the US, and through a combination of distributors and direct sales representatives outside the US. The company has 89 manufacturing facilities and serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide.

DePuy Synthes is a major player in the global CSF management market. It is a Johnson & Johnson Company and offers a comprehensive portfolio of orthopedic and neurosurgery products and services, including products for CSF management. The firm has its presence in the US, Canada, Latin America, Europe, the Middle East, Asia, and Africa. It is well established in the US market and has a significant market penetration internationally with global reach in more than 60 countries.

Full Press Release : https://www.prnewswire.com/news-releases/cerebrospinal-fluid-csf-management-market-worth-156-billion-usd-by-2022-682677991.html

Some of the other players competing in this market are B. Braun (Germany), and Integra (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd (Taiwan).